Géraud Dautzenberg

Validating the MoCA for screening

REFERENCES American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (revised 4th ed.) . Washington, DC: American Psychiatric Association. Ballard, C. K. et al. (2015) ‘Helping you to assess cognition: A practical toolkit for clinicians’, Alzheimer’s Society and Department of Health , pp. 1–42. Available at: https://www.alzheimers.org.uk/download/ downloads/id/3475/alzheimers_society_cognitive_assessment_toolkit.pdf. Baune, B. T. and Renger, L. (2014) ‘Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression - A systematic review’, Psychiatry Research . doi: 10.1016/j.psychres.2014.05.013. Bierman, E. J. M. et al. (2005) ‘Effects of anxiety versus depression on cognition in later life’, American Journal of Geriatric Psychiatry , 13(8), pp. 686–693. doi: 10.1097/00019442-200508000-00007. Bora, E. and Pantelis, C. (2015) ‘Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls’, Schizophrenia Bulletin , 41(5), pp. 1095–1104. doi: 10.1093/schbul/sbu198. Borson, S. et al. (2013) ‘Improving dementia care: The role of screening and detection of cognitive impairment’, Alzheimer’s and Dementia . Elsevier Inc., pp. 151–159. doi: 10.1016/j.jalz.2012.08.008. Bossuyt, P. M. et al. (2015) ‘STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies’, Clinical Chemistry , 61(12), pp. 1446–1452. doi: 10.1373/clinchem.2015.246280. Brunet, M. D. et al. (2013) ‘There is no evidence base for proposed dementia screening’, BMJ (Online) . doi: 10.1136/bmj.e8588. Burn, A. M. et al. (2018) ‘Dementia case-finding in hospitals: A qualitative study exploring the views of healthcare professionals in English primary care and secondary care’, BMJ Open . BMJ Publishing Group, 8(3), p. e020521. doi: 10.1136/bmjopen-2017-020521. Carson, N., Leach, L. and Murphy, K. J. (2018) ‘A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores’, International Journal of Geriatric Psychiatry , 33(2), pp. 379–388. doi: 10.1002/ gps.4756. Chambers, L. W., Sivananthan, S. and Brayne, C. (2017) ‘Is Dementia Screening of Apparently Healthy Individuals Justified?’, Advances in Preventive Medicine . Hindawi Limited, 2017, pp. 1–8. doi: 10.1155/2017/9708413. De Craen, A. J. M., Heeren, T. J. and Gussekloo, J. (2003) ‘Accuracy of the 15-item geriatric depression scale (GDS-15) in a community sample of the oldest old’, International Journal of Geriatric Psychiatry . doi: 10.1002/gps.773. Dautzenberg, G. et al. (2018) ‘Severe Cognitive Impairment Associated with a High Free but Therapeutic Total Concentration of Valproic Acid Due to Hypoalbuminemia in an Older Patient with Bipolar Disorder’, Journal of Clinical Psychopharmacology . Lippincott Williams and Wilkins, pp. 265– 268. doi: 10.1097/JCP.0000000000000872. Davis, D. H. J. et al. (2013) ‘Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: A generic protocol for cross-sectional and delayed-verification studies’, Cochrane Database of Systematic Reviews , 2013(3). doi: 10.1002/14651858.CD010460. Davis, D. H. J. et al. (2015) ‘Montreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementias’, Cochrane Database of Systematic Reviews . doi: 10.1002/14651858.CD010775.pub2.

3

81